Craniosynostosis in patients with noonan syndrome caused by germline KRAS mutations

American Journal of Medical Genetics, Part A

Volumn 149, Issue 5, 2009, Pages 1036-1040

  Kratz, Christian P ^a   Zampino, Giuseppe ^b   Kriek, Marjolein ^c   Kant, Sarina G ^c   Leoni, Chiara ^b   Pantaleoni, Francesca ^d   Oudesluys Murphy, Anne Marie ^c   Rocco, Concezio Di ^b   Kloska, Stephan P ^e   Tartaglia, Marco ^d   Zenker, Martin ^f,g  

^a UNIVERSITY OF FREIBURG   (Germany)

^b CATHOLIC UNIVERSITY   (Italy)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^g UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Craniosynostosis; KRAS; Noonan syndrome

Indexed keywords

ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CRANIOFACIAL SYNOSTOSIS; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; INFANT; MALE; NOONAN SYNDROME; ONCOGENE K RAS; PRIORITY JOURNAL;

CHILD, PRESCHOOL; CRANIOSYNOSTOSES; DNA MUTATIONAL ANALYSIS; GERM-LINE MUTATION; HUMANS; MALE; MUTATION; NOONAN SYNDROME; PROTO-ONCOGENE PROTEINS; RAS PROTEINS;

EID: 66849104468     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.32786     Document Type: Article

References (24)

1. Bertola DR, Pereira AC, Brasil AS, Albano LM, Kim CA, Krieger JE. 2007. Further evidence of genetic heterogeneity in Costello syndrome: Involvement of the KRAS gene. J Hum Genet 52:521-526.
2. Carta C, Pantaleoni F, Bocchinfuso G, Stella L, Vasta I, Sarkozy A, Digilio C, Palleschi A, Pizzuti A, Grammatico P, Zampino G, Dallapiccola B, Gelb BD, Tartaglia M. 2006. Germline missense mutations affecting KRAS Isoform B are associated with a severe Noonan syndrome phenotype. Am J Hum Genet 79:129-135.
3. Cohen MM Jr. 1986. Craniosynostosis: Diagnosis, evaluation and management. New York:Raven Press.
4. Mitin N, Rossman KL, Der CJ. 2005. Signaling interplay in Ras superfamily function. Curr Biol 15:R563-R574.
5. Nava C, Hanna N, Michot C, Pereira S, Pouvreau N, Niihori T, Aoki Y, Matsubara Y, Arveiler B, Lacombe D, Pasmant E, Parfait B, Baumann C, Heron D, Sigaudy S, Toutain A, Rio M, Goldenberg A, Leheup B, Verloes A, Cave H. 2007. Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signaling pathway: Genotype-phenotype relationships and overlap with Costello syndrome. J Med Genet 44: 763-771.
6. Niihori T, Aoki Y, Narumi Y, Neri G, Cave H, Verloes A, Okamoto N, Hennekam RC, Gillessen-Kaesbach G, Wieczorek D, Kavamura MI, Kurosawa K, Ohashi H, Wilson L, Heron D, Bonneau D, Corona G, Kaname T, Naritomi K, Baumann C, Matsumoto N, Kato K, Kure S, Matsubara Y. 2006. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. Nat Genet 38:294-296.
7. Nystrom AM, Ekvall S, Berglund E, Bjorkqvist M, Braathen G, Duchen K, Enell H, Holmberg E, Holmlund U, Olsson-Engman M, Anneren G, Bondeson ML. 2008. Noonan and cardio-facio-cutaneous syndromes: Two clinically and genetically overlapping disorders. J Med Genet 45:500-506.
8. Pandit B, Sarkozy A, Pennacchio LA, Carta C, Oishi K, Martinelli S, Pogna EA, Schackwitz W, Ustaszewska A, Landstrom A, Bos JM, Ommen SR, Esposito G, Lepri F, Faul C, Mundel P, Lopez Siguero JP, Tenconi R, Selicorni A, Rossi C, Mazzanti L, Torrente I, Marino B, Digilio MC, Zampino G, Ackerman MJ, Dallapiccola B, Tartaglia M, Gelb BD. 2007. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet 39: 1007-1012.
9. Razzaque MA, Nishizawa T, Komoike Y, Yagi H, Furutani M, Amo R, Kamisago M, Momma K, Katayama H, Nakagawa M, Fujiwara Y, Matsushima M, Mizuno K, Tokuyama M, Hirota H, Muneuchi J, Higashinakagawa T, Matsuoka R. 2007. Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nat Genet 39:1013-1017.
10. Roberts AE, Araki T, Swanson KD, Montgomery KT, Schiripo TA, Joshi VA, Li L, Yassin Y, Tamburino AM, Neel BG, Kucherlapati RS. 2007. Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet 39:70-74.
11. Schubbert S, Zenker M, Rowe SL, Boll S, Klein C, Bollag G, van der Burgt I, Musante L, Kalscheuer V, Wehner LE, Nguyen H, West B, Zhang KY, Sistermans E, Rauch A, Niemeyer CM, Shannon K, Kratz CP. 2006. Germline KRAS mutations cause Noonan syndrome. Nat Genet 38: 331-336.
12. Shukla V, Coumoul X, Wang RH, Kim HS, Deng CX. 2007. RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis. Nat Genet 39: 1145-1150.
13. Sovik O, Schubbert S, Houge G, Steine SJ, Norgard G, Engelsen B, Njolstad PR, Shannon K, Molven A. 2007. De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features. J Med Genet 44:e84.
14. Tartaglia M, Gelb BD. 2009. Molecular genetics ofNoonan syndrome. In: Zenker M, editor. Noonan syndrome and related disorders: A matter of deregulated RAS signaling. Basel:Karger Press. p 20-39.
15. Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, van der Burgt I, Crosby AH, Ion A, Jeffery S, Kalidas K, Patton MA, Kucherlapati RS, Gelb BD. 2001. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29:465-468.
16. Tartaglia M, Kalidas K, Shaw A, SongX, Musat DL, van der Burgt I, Brunner HG, Bertola DR, Crosby A, Ion A, Kucherlapati RS, Jeffery S, Patton MA, Gelb BD. 2002. PTPN11 mutations in Noonan syndrome: Molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 70:1555-1563.
17. Tartaglia M, Martinelli S, Stella L, Bocchinfuso G, Flex E, Cordeddu V, Zampino G, Burgt I, Palleschi A, Petrucci TC, Sorcini M, Schoch C, Foa R, Emanuel PD, Gelb BD. 2006. Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. Am J Hum Genet 78:279-290.
18. Tartaglia M, Pennacchio LA, Zhao C, Yadav KK, Fodale V, Sarkozy A, Pandit B, Oishi K, Martinelli S, Schackwitz W, Ustaszewska A, Martin J, Bristow J, Carta C, Lepri F, Neri C, Vasta I, Gibson K, Curry CJ, Siguero JP, Digilio MC, Zampino G, Dallapiccola B, Bar-Sagi D, Gelb BD. 2007. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet 39:75-79.
19. Wennerberg K, Rossman KL, Der CJ. 2005. The Ras superfamily at a glance. J Cell Sci 118:843-846.
20. Wilkie AO. 1997. Craniosynostosis: Genes and mechanisms. Hum Mol Genet 6:1647-1656.
21. Wilkie AO. 2007. Cancer drugs to treat birth defects. Nat Genet 39:1057-1059.
22. Zenker M, Buheitel G, Rauch R, Koenig R, Bosse K, Kress W, Tietze HU, Doerr HG, Hofbeck M, Singer H, Reis A, Rauch A. 2004. Genotype- phenotype correlations in Noonan syndrome. J Pediatr 144:368-374.
23. Zenker M, Horn D, Wieczorek D, Allanson J, Pauli S, van der Burgt I, Doerr HG, Gaspar H, Hofbeck M, Gillessen-Kaesbach G, Koch A, Meinecke P, Mundlos S, Nowka A, Rauch A, ReifS, von Schnakenburg C, Seidel H, Wehner LE, Zweier C, Bauhuber S, Matejas V, Kratz CP, Thomas C, Kutsche K. 2007a. SOS1 is the second most common Noonan gene but plays no major role in cardio-facio-cutaneous syndrome. J Med Genet 44:651-656.
24. Zenker M, Lehmann K, Schulz AL, Barth H, Hansmann D, Koenig R, Korinthenberg R, Kreiss-Nachtsheim M, Meinecke P, Morlot S, Mundlos S, Quante AS, Raskin S, Schnabel D, Wehner LE, Kratz CP, Horn D, Kutsche K. 2007b. Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations. J Med Genet 44:131-135.